SANUWAVE Health, Inc. (NasdaqGM: SNWV)
Health Care · Health Care Equipment & Supplies · US
$4.67
+1.30% today · -89.2% 1Y
SANUWAVE Health, Inc. (NasdaqGM: SNWV) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $39.66M and employs 55 people.
Over the last twelve months the share price has lost 89.2%, trading between 4.57 and 45.33.
Tweenvest scores SANUWAVE Health, Inc. across four factors: quality 49/100, value 65/100. Its strongest factor is value.
SNWV price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $39.66M
- Revenue (TTM)
- $44.02M
- P/E
- 5.90
- EPS
- 0.78
- Dividend yield
- —
- Beta (5Y)
- 1.50
- 52-week high
- $45.33
- 52-week low
- $4.57
- Avg volume (3M)
- —
- Shares outstanding
- 8.60M
- Employees
- 55
- Next earnings
- —
About SANUWAVE Health, Inc.
SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. The company was founded on May 6, 2004 and is headquartered in Eden Prairie, MN.
- ISIN
- US80303D3052
- Founded
- 2004
- Listed since
- Oct 18, 2024
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $200.95B | $116.13 | -0.46% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.36B | $371.84 | -0.46% |
| Stryker CorporationNYSE: SYK | $126.81B | $330.59 | +0.85% |
| Medtronic plcNYSE: MDT | $116.66B | $91.14 | -1.89% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.36B | €159.15 | -1.58% |
| Boston Scientific CorporationNYSE: BSX | $72.26B | $49.86 | +1.73% |
| HOYA CorporationTSE: 7741 | $52.49B | ¥24,995.00 | +0.40% |
| Edwards Lifesciences CorporationNYSE: EW | $52.38B | $90.87 | +0.41% |
Figures last refreshed Aug 18, 2026.